Article Versions Notes

Almasoudi HH, Mashraqi MM, Alshamrani SA, Alharthi AA, Alsalmi O, Nahari MH, Al-Mansour FSH, Alhazmi AYM. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor. Pharmaceuticals. 2024; 17(2):208. https://doi.org/10.3390/ph17020208

Almasoudi, Hassan Hussain, Mutaib M. Mashraqi, Saleh A. Alshamrani, Afaf Awwadh Alharthi, Ohud Alsalmi, Mohammed H. Nahari, Fares Saeed H. Al-Mansour, and Abdulfattah Yahya M. Alhazmi. 2024. "Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor" Pharmaceuticals 17, no. 2: 208. https://doi.org/10.3390/ph17020208

Almasoudi, H. H., Mashraqi, M. M., Alshamrani, S. A., Alharthi, A. A., Alsalmi, O., Nahari, M. H., Al-Mansour, F. S. H., & Alhazmi, A. Y. M. (2024). Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor. Pharmaceuticals, 17(2), 208. https://doi.org/10.3390/ph17020208